RET c.2753T>G ;(p.M918R)

Variant ID: 10-43617416-T-G

NM_020975.4(RET):c.2753T>G;(p.M918R)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases.

Scientific Reports
Šimčíková, Daniela D; Heneberg, Petr P
Publication Date: 2019-12-09

Variant appearance in text: RET: M918R
PubMed Link: 31819097
Variant Present in the following documents:
  • 41598_2019_54976_MOESM2_ESM.xlsx, sheet 8
View BVdb publication page



Targeted treatment of differentiated and medullary thyroid cancer.

Journal Of Thyroid Research
Bales, Shannon R SR; Chopra, Inder J IJ
Publication Date: 2011

Variant appearance in text: MEN2B: M918R
PubMed Link: 21826256
Variant Present in the following documents:
  • Main text
  • JTR2011-102636.pdf
View BVdb publication page



Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Wells, Samuel A SA; Gosnell, Jessica E JE; Gagel, Robert F RF; Moley, Jeffrey J; Pfister, David D; Sosa, Julie A JA; Skinner, Michael M; Krebs, Annetta A; Vasselli, James J; Schlumberger, Martin M
Publication Date: 2010-02-10

Variant appearance in text: RET: M918R
PubMed Link: 20065189
Variant Present in the following documents:
  • Main text
View BVdb publication page